Anuh Pharma Q3 FY26 profit jumps 30 percent on 24 percent revenue growth

Revenue Growth 20pctPat Growth 25pctEbitda Margin ExpansionResults View source PDF Explain this filing

ANUHPHR · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+3.4%Reaction day

₹79.95

prior close

₹84.14

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+2.6%+0.8% vs market

Pharmaceuticals peers, median of 159sector+1.8%+1.7% vs sector

On the reaction day the stock moved 0.8 pts more than Nifty Microcap 250 and 1.7 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-1.3

10m

-1.0

15m

-1.4

30m

-1.4

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+3.4+2.6+0.8+1.8+1.7

Next day

+4.6+3.6+1.0+2.4+2.3

+3.2+3.1+0.1+2.0+1.2

+2.0+2.6-0.6+1.2+0.8

+1.2+1.1+0.1+0.7+0.5

+1.2+0.3+0.9+0.0+1.2

-2.5+1.6-4.1+0.8-3.3

15d

-3.1-3.9+0.9-4.4+1.3

-2.4-8.1+5.7-5.3+2.8

-1.8-3.1+1.3-3.0+1.1

+3.8+9.2-5.3+5.0-1.2

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 159Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Anuh Pharma posted strong Q3 FY26 results. Revenue from operations rose 23.6 percent YoY to Rs 19,717.81 lakhs. Nine month revenue grew 22.9 percent to Rs 56,954.02 lakhs. Q3 PAT surged 30 percent to Rs 1,345.10 lakhs from Rs 1,034.31 lakhs. However 9M PAT fell 15.8 percent to Rs 2,936.47 lakhs. Q3 EBITDA margin expanded to 10.60 percent from 9.86 percent but 9M margin compressed to 8.33 percent from 10.85 percent. Bonus shares 1:1 were allotted in July 2025. New labour codes added Rs 48.31 lakhs to employee costs. Auditors gave a clean limited review report.

Likely market impact

Strong quarterly show lifts sentiment, though 9M profit dip and margin pressure may cap upside. Bonus shares already factored in.